• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

KYTHERA Biopharmaceuticals Inc

+ Add to Watchlist

KYT1:GR

25.753 EUR 0.979 3.66%

As of 02:03:17 ET on 10/01/2014.

Snapshot for KYTHERA Biopharmaceuticals Inc (KYT1)

Open: 25.753 Day's Range: 25.753 - 25.753 Volume: 0
Previous Close: 26.732 52wk Range: 21.435 - 40.807 1-Yr Rtn: -23.35%

Stock Chart for KYT1

No chart data available.
  • KYT1:GR 25.753
  • 1D
  • 1M
  • 1Y
26.732
Interactive KYT1 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for KYT1

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -3.9180
Est. PEG Ratio -
Market Cap (M EUR) 583.89
Shares Outstanding (M) 22.67
30 Day Average Volume 0
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/14/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for KYT1

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for KYT1

KYTHERA Biopharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. The Company discovers, develops, and commercializes prescription products such as submental fat reduction medicine for the aesthetics medicine market. KYTHERA Biopharmaceuticals operates in the United States.

Keith R Leonard JrPresident/CEO/Co-FounderJohn W SmitherChief Financial Officer
Frederick Beddingfield IIIChief Medical OfficerJeffrey D WebsterSenior VP:Operations
More Company Profile & Key Executives for KYT1

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil